132 related articles for article (PubMed ID: 1424240)
1. Ring chromosome 22 and neurofibromatosis.
Tommerup N; Warburg M; Gieselmann V; Hansen BR; Koch J; Petersen GB
Clin Genet; 1992 Oct; 42(4):171-7. PubMed ID: 1424240
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
3. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
[TBL] [Abstract][Full Text] [Related]
4. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
Kehrer-Sawatzki H; Udart M; Krone W; Baden R; Fahsold R; Thomas G; Schmucker B; Assum G
Hum Genet; 1997 Jul; 100(1):67-74. PubMed ID: 9225971
[TBL] [Abstract][Full Text] [Related]
6. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
7. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
8. Constitutional ring chromosomes and tumour suppressor genes.
Tommerup N; Lothe R
J Med Genet; 1992 Dec; 29(12):879-82. PubMed ID: 1336057
[TBL] [Abstract][Full Text] [Related]
9. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the literature.
Ziats CA; Jain L; McLarney B; Vandenboom E; DuPont BR; Rogers C; Sarasua S; Nevado J; Cordisco EL; Phelan K; Boccuto L
Eur J Med Genet; 2020 Nov; 63(11):104042. PubMed ID: 32822873
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of vestibular schwannoma in ring chromosome 22.
Denayer E; Brems H; de Cock P; Evans GD; Van Calenbergh F; Bowers N; Sciot R; Debiec-Rychter M; Vermeesch JV; Fryns JP; Legius E
BMC Med Genet; 2009 Sep; 10():97. PubMed ID: 19772601
[TBL] [Abstract][Full Text] [Related]
12. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
[TBL] [Abstract][Full Text] [Related]
13. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma.
Cogen PH; Daneshvar L; Bowcock AM; Metzger AK; Cavalli-Sforza LL
Cancer Genet Cytogenet; 1991 Jun; 53(2):271-7. PubMed ID: 1676608
[TBL] [Abstract][Full Text] [Related]
17. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
[TBL] [Abstract][Full Text] [Related]
18. [Selected problems of neurofibromatosis with presentation of a case of multiple intracranial and intramedullary tumors].
Stachura Z; Zralek C; Siemianowicz S; Kiczka-Zralek M; Zawadzki T; Kluczewska E; Giec-Lorenc A
Neurol Neurochir Pol; 1998; 32(6):1563-9. PubMed ID: 10358844
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of chromosome 22 deletions in schwannomas.
Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
[TBL] [Abstract][Full Text] [Related]
20. 46,XY del(18)(q21.3q22.2) with mosaicism of r(18) and a milder form of the 18q- syndrome.
Maaswinkel-Mooij PD; de Jong P; Beverstock GC
Clin Genet; 1993 Feb; 43(2):76-8. PubMed ID: 8448905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
